Biopharma Business

Tag "study data"

Most approved oncology drugs do not offer better survival rate or quality of life, say researchers

    Most approved oncology drugs do not offer better survival rate or quality of life, say researchers

A retrospective cohort study, published in the British Medical Journal, has found no conclusive evidence that most oncology treatments approved for use by the European Medicines Agency (EMA) offered survival

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements